Clinical efficacy of cytoreductive surgery and hyperthermic chemotherapy in peritoneal carcinomatosis from gastric cancer

Expert Review of Anticancer Therapy

Volumn 11, Issue 10, 2011, Pages 1505-1508

  Ströhlein, Michael A ^a   Bulian, Dirk R ^a   Heiss, Markus M ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

cytoreductive surgery; gastric cancer; hyperthermic intraperitoneal chemotherapy (HIPEC); peritoneal carcinomatosis

Indexed keywords

CISPLATIN; MITOMYCIN;

ADVERSE OUTCOME; ANASTOMOSIS LEAKAGE; ARTICLE; BONE MARROW DEPRESSION; BRAIN HEMORRHAGE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CYTOREDUCTIVE SURGERY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTHERMIC THERAPY; INTESTINE OBSTRUCTION; OVERALL SURVIVAL; RESPIRATORY FAILURE; SEPSIS; STOMACH CANCER; SURVIVAL TIME;

EID: 80054734923     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.11.147     Document Type: Article

References (17)

1. Yang XJ, Huang CQ, Suo T et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: fnal results of a Phase III randomized clinical trial. Ann. Surg. Oncol. 18(6), 1575-1581 (2011).
2. Sugarbaker PH, Yu W, Yonemura Y. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer. Semin. Surg. Oncol. 21(4), 233-248 (2003). (Pubitemid 37521721)
3. Sugarbaker PH, Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 58(2), 96-107 (2000). (Pubitemid 30113860)
4. Yonemura Y, Elnemr A, Endou Y et al. Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J. Gastrointest. Oncol. 2(2), 85-97 (2010).
5. Sadeghi B, Arvieux C, Glehen O et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2), 358-363 (2000). (Pubitemid 30051820)
6. Boku N. Chemotherapy for metastatic disease: review from JCOG trials. Int. J. Clin. Oncol. 13(3), 196-200 (2008). (Pubitemid 351876992)
7. Sugarbaker PH. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol. 7(1), 69-76 (2006). (Pubitemid 43025395)
8. Elias D, Lefevre JH, Chevalier J et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J. Clin. Oncol. 27(5), 681-685 (2009).
9. Elias D, Pocard M, Goere D. HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. Cancer Treat. Res. 134, 303-318 (2007).
10. Glehen O, Gilly FN, Arvieux C et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann. Surg. Oncol. 17(9), 2370-2377 (2010).
11. Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Brit. J. Surg. 92(3), 370-375 (2005). (Pubitemid 40445602)
12. Hall JJ, Loggie BW, Shen P et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J. Gastrointest. Surg. 8(4), 454-463 (2004). (Pubitemid 38561210)
13. Yonemura Y, Endou Y, Sasaki T et al. Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur. J. Surg. Oncol. 36(12), 1131-1138 (2010).
14. Glehen O, Gilly FN, Cotte E. Hyperthermic intraperitoneal chemotherapy in advanced gastric cancer: the end of skepticism? Ann. Surg. Oncol. 18(6), 1524-1526 (2011).
15. Ströhlein MA, Lordick F, Rüttinger D et al. Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, Phase I/II trial. Onkologie 34(3), 101-110 (2011).
16. Glockzin G, Schlitt HJ, Piso P. Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J. Surg. Oncol. 7, 5 (2009).
17. Cunningham D, Allum WH, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Eng. J. Med. 355(1), 11-20 (2006).